"More than 30 percent of cancer patients will try some kind of alternative therapy," says Dr. Roberta Lee, vice chair of the Department of Integrative Medicine at Beth Israel Medical Center and medical director of the Continuum Center for Health and Healing. "As at treatment on its own, alternative therapy is complicated and risky. But when it is supportive, it is a good strategy."
Collection of YouTube videos featuring Dr. Isaac Eliaz, integrative health expert.
Collection of videos featuring Dr. Isaac Eliaz on World News.
Dr. Isaac Eliaz, a pioneer in the field of integrative medicine since the early 1980s, is a respected author, lecturer, researcher, product formulator and clinical practitioner. Since 1991, Dr. Eliaz has maintained a busy private practice in northern California that focuses primarily on integrative, holistic protocols for cancer patients. He leads an integrative medical team at Amitabha Clinic in Sebastopol, California with focus on cancer and other chronic ailments.
Botanical Formula Delivers Powerful Support for Breast Health Read Dr. Eliaz’s article published the October 2012 issue of the Nutraceutical Business & Technology Journal, reprinted here for our readers: Not long ago, there was a stark dividing line between pharmaceutical drugs and nutritional supplements. The perception was that pharmaceuticals are intensely researched (which they are) and
A new study shows Modified Citrus Pectin makes safer, lower chemotherapy doses possible. This is important news for cancer treatment and prevention.
In my own clinical practice, I have seen remarkable results with breast cancer patients using a combination of targeted botanicals and integrative approaches. My practice of patient-driven medicine and the results I witnessed using powerful combinations of natural ingredients were the driving force behind the years of work and research...
Synergy is an important therapeutic strategy, especially when fighting against cancer. In order to outsmart this insidious disease, a multi-pronged, synergistic approach has shown to be the most successful.
Carefree, Ariz., (March 6, 2012) -- Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and researcher, presents Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases. He also shared new research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker. Dr. Eliaz's latest presentation was given to hundreds of integrative oncologists during the Oncology Association of Naturopathic Physician's 2012 Convention (OncANP).
Prostate cancer remains a leading cause of cancer related death for men in developed countries. One in six men will fight prostate cancer in their lifetime and in many cases this disease is aggressive and difficult to treat using conventional therapies alone. Researchers are constantly seeking safe and effective methods to halt or slow prostate cancer progression ...